RDPTF — Radiopharm Theranostics Ltd
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1949257 ·
Australia
Last close
$0.01
Market Cap
$28.89M
52W High
$0.02
52W Low
$0.00
ADV30
0
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Balance + Analyst (yfinance extras)
Retained Earnings
$-127,785,301
Inventory
—
Receivables
$6,250,693
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$13,502,270
EBITDA
$-49,613,928
Free Cash Flow
$-30,744,724
Enterprise Value
$17,117,056
Total Cash
$4,138,074
Total Debt
$0
Shares Out
4,337,549,491
Trailing EPS
$-0.01
Book Value
$0.01
ROE
-174.7%
ROA
-44.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 2,767,888 | -58,223,929 | -56,950,494 | 60,133,579 | 37,809,896 | 24,687,209 | — |
| Jun 2025 | 3,633,422 | -34,640,735 | -38,342,457 | 86,481,876 | 43,609,972 | 44,792,004 | — |
| Jun 2024 | 299,228 | -37,173,885 | -47,949,119 | 72,036,345 | 44,683,059 | 28,122,562 | — |
| Jun 2023 | 292,359 | -31,690,601 | -34,611,194 | 74,949,668 | 29,370,243 | 44,384,488 | — |
| Jun 2022 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PMN | ProMIS Neurosciences Inc. | $28.88M | $3.21 | — |
| AYTU | AYTU BIOPHARMA, INC | $28.91M | $2.66 | — |
| SCYX | SCYNEXIS INC | $28.37M | $2.85 | — |
| PYRGF | PyroGenesis Canada Inc. | $28.34M | $0.13 | — |
| PRRUF | IMMUTEP Ltd | $29.47M | $0.02 | — |
News headlines (Yahoo Finance, 1h cache)
Radiopharm Theranostics Presents Interim Analysis from Phase 2b Imaging Study of RAD101 in Suspected Recurrent Brain Metastases Following Radiotherapy at the Society for Neuro-Oncology Annual Meeting
2026-11-16 13:00 · Yahoo
UPDATE – International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 12, 2026
2026-11-09 16:56 · Yahoo
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 12, 2026
2026-11-05 13:35 · Yahoo
Radiopharm Theranostics Announces Alignment with U.S. FDA on Single Pivotal Phase 3 Trial for RAD101 in Diagnosis of Brain Metastases
2026-11-04 12:00 · Yahoo
Radiopharm Theranostics Reports Business Update
2026-11-02 13:00 · Yahoo
GE HealthCare Wins Approval for MINItrace Magni Cyclotron in Europe
2026-10-20 13:00 · Yahoo
Radiopharm Completes Productive End-of-Phase 2 Meeting with U.S. Food and Drug Administration for Pivotal Development Program of RAD101
2026-10-05 12:00 · Yahoo
Edison Issues Report on Starpharma (SPL)
2026-09-30 08:23 · Yahoo
Radiopharm Theranostics Selected for Late-Breaking Oral Presentation of Positive Data from Interim Analysis of U.S. Phase 2b Imaging Trial of RAD101 at 2026 Society of Neuro-Oncology Annual Meeting
2026-09-14 12:00 · Yahoo
Radiopharm Theranostics Announces Positive Data from the Phase 1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal Adenocarcinoma
2026-09-09 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.